Biopharma Company Reaches Phase 3 for Cancer Treatments; 9 Patents; Collaboration with Imugene: RenovoRx NASDAQ: RNXT
$RXNT is a Clinical-Stage Biopharma Company Developing Proprietary Targeted Combination Therapies for High Unmet Medical Needs in Oncology. RenovoRx, Inc. (NASDAQ: RNXT) LOS ALTOS, CALIFORNIA, UNITED STATES, December 12, 2023 /EINPresswire.com/ -- …